Interventions for neovascular age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Evans, Jennifer R ^a   Virgili, Gianni ^b   Gordon, Iris ^a   Bunce, Catey ^c   Chakravarthy, Usha ^d   Desai, Parul ^c   Fletcher, Astrid ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANECORTAVE; BEVACIZUMAB; GLYCOPROTEIN; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN; VERTEPORFIN;

CLINICAL TRIAL; DATA ANALYSIS; DATA EXTRACTION; DATA SYNTHESIS; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; LASER COAGULATION; QUALITY CONTROL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; THERAPY EFFECT;

EID: 70249100582     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007650     Document Type: Review

References (9)

1. Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Archives of Pediatrics & Adolescent Medicine 2008;162(2):111-116 (Pubitemid 351240712)
2. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290(15):2057-2060 (Pubitemid 37430590)
3. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004;122(4):564-572
4. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, et al. Indirect comparisons of competing interventions. Health Technology Assessment (Winchester, England) 2005;9(26):1-134, iii-iv.
5. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490-1494
6. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age-related macular degeneration in the United Kingdom?. British Journal of Ophthalmology 2003;87 (3):312-317 (Pubitemid 36307906)
7. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Research Methodology 2007;7:10. (Pubitemid 46364967)
8. Wilczynski NL, Haynes RB. EMBASE search strategies achieved high sensitivity and specificity for retrieving methodologically sound systematic reviews. Journal of Clinical Epidemiology 2007;60(1):29-33.
9. Wong T, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 2008;115(1):116-126